WILLIAM DAVIS: Open Payments
NPI 1598229676 · FAYETTEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 124 payments from 21 companies in 2025. Trend: 2023 $2,357 · 2024 $2,237 · 2025 $2,410
Food & beverage: $2,340Education: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $348 |
| AstraZeneca Pharmaceuticals LP | 16 | $317 |
| PFIZER INC. | 14 | $301 |
| Novo Nordisk Inc | 13 | $196 |
| Dexcom, Inc. | 7 | $166 |
| Astellas Pharma US Inc | 4 | $154 |
| Lilly USA, LLC | 5 | $118 |
| Axsome Therapeutics, Inc. | 5 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $115 |
| Amgen Inc. | 6 | $104 |
Products named: VRAYLAR, ELIQUIS, Dexcom G6 Transmitter, JARDIANCE, Auvelity, CAPLYTA, FARXIGA, UBRELVY.
Industry payments across NC — which companies pay providers there.
